Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

• Main Authors: Antonio Rodríguez-Miguel (Author), Beatriz Fernández-Fernández (Author), Alberto Ortiz (Author), Miguel Gil (Author), Sara Rodríguez-Martín (Author), Gema Ruiz-Hurtado (Author), Encarnación Fernández-Antón (Author), Luis M. Ruilope (Author), Francisco J. de Abajo (Author)
• Format: Book
• Published: MDPI AG, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background/Objectives:</b> The burden of chronic kidney disease (CKD) is increasing, as is the prevalence of type 2 diabetes mellitus (T2DM). Post-hoc analyses of clinical trials support that sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptors ago...